Overexpression of heat shock protein 27 (HSP 27) increases gemcitabine sensitivity in pancreatic cancer cells through S‐phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke, E Kampmann… - Journal of cellular …, 2015 - Wiley Online Library
We previously established a role for HSP 27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

[PDF][PDF] Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs… - academia.edu
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke… - Journal of cellular …, 2015 - pubmed.ncbi.nlm.nih.gov
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

Overexpression of heat shock protein 27 (HSP 27) increases gemcitabine sensitivity in pancreatic cancer cells through S‐phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke… - Journal of Cellular …, 2015 - search.proquest.com
We previously established a role for HSP 27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

[PDF][PDF] Overexpression of Heat-Shock Protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through s-phase arrest and apoptosis

Y Guo - 2014 - edoc.ub.uni-muenchen.de
Pancreatic cancer is a highly aggressive cancer with gemcitabine as its standard therapeutic
basis. We previously established a role for HSP27 as a prognostic and predictive marker in …

[PDF][PDF] Overexpression of Heat-Shock Protein 27 (HSP27) Increases Gemcitabine Sensitivity in Pancreatic Cancer Cells through S-Phase Arrest and Apoptosis

Y Guo - 2014 - core.ac.uk
Pancreatic cancer is a highly aggressive cancer with gemcitabine as its standard therapeutic
basis. We previously established a role for HSP27 as a prognostic and predictive marker in …

[PDF][PDF] Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs… - J. Cell. Mol. Med, 2015 - Citeseer
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.

Y Guo, A Ziesch, S Hocke, E Kampmann… - Journal of Cellular …, 2014 - europepmc.org
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

[PDF][PDF] Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs… - researchgate.net
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …

[PDF][PDF] Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs… - J. Cell. Mol. Med, 2015 - infusio.org
We previously established a role for HSP27 as a predictive marker for therapeutic response
towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms …